Nesuparib (JPI-547/OCN-201) is a potent PARP inhibitor with inhibitory effects on PARP and TNKS1.Nesuparib has antitumor activity and can be used in the treatment of tumors, endocrine and metabolic disorders, genitourinary disorders, and can be used in the study of neuropathic pain, neurodegenerative disorders, and cardiovascular diseases.
Molecular Weight:
400.48
Purity:
99.94%
CAS Number:
[2055357-64-5]
Formula:
C23H24N6O
Target:
Wnt/beta-catenin|||PARP
T61932
* VAT and and shipping costs not included. Errors and price changes excepted